Legend Biotech earnings were -$296.8M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest LEGN earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$30.9M, down 22.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LEGN reported annual earnings of -$296.8M, with 67.7% growth. The next LEGN earnings date is May 19, 2026.
On LEGN's earnings call on Invalid Date, Legend Biotech (NASDAQ: LEGN) reported Q4 2025 earnings per share (EPS) of -$0.16, up 214.29% year over year. Total LEGN earnings for the quarter were -$30.90 million. In the same quarter last year, Legend Biotech's earnings per share (EPS) was $0.14.
The next LEGN earnings call is Invalid Date. Add LEGN to your watchlist to be reminded of Legend Biotech's next earnings date.
Is Legend Biotech profitable or losing money?
As of the last Legend Biotech earnings report, Legend Biotech is currently losing money. Legend Biotech's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$296.80 million, a 67.68% increase year over year.
What was LEGN's earnings growth in the past year?
As of Legend Biotech's earnings date in Invalid Date, Legend Biotech's earnings has grown year over year. LEGN earnings in the past year totalled -$296.80 million.
What are Legend Biotech's earnings expectations?
The current EPS estimate for Legend Biotech's earnings report in Invalid Date is $0.01.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.